All In Biotech

Drug Trial Radar · NCT02470091

Denosumab in Treating Patients With Recurrent or Refractory Osteosarcoma

Phase 2 Study of Denosumab (NSC# 744010), a RANK Ligand Antibody, for Recurrent or Refractory Osteosarcoma

Last checked: Nov 19, 2026Latest source record: Jan 22, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

56

Actual

Start

Nov 21, 2015

Primary completion

Dec 31, 2019

Study completion Dec 31, 2023

Sponsor

Lead sponsor
Children's Oncology GroupResearch network
Sponsor type
Research network
Collaborators
National Cancer Institute (NCI)
First posted
Jun 12, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 11 years, up to 49 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This phase II trial studies how well denosumab works in treating patients with osteosarcoma that has come back (recurrent) or does not respond to treatment (refractory). Immunotherapy with monoclonal antibodies, such as denosumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread.

Conditions

  • Metastatic Osteosarcoma
  • Recurrent Osteosarcoma
  • Refractory Osteosarcoma
  • Stage IV Osteosarcoma AJCC v7
  • Stage IVA Osteosarcoma AJCC v7
  • Stage IVB Osteosarcoma AJCC v7

Interventions

  • DenosumabBiological

    Given SC

  • Laboratory Biomarker AnalysisOther

    Correlative studies

  • Pharmacological StudyOther

    Correlative studies

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Disease Control Rate (Cohort I)Time frame: At 4 months
  2. Response Evaluation Criteria in Solid Tumors (RECIST) Response (Complete Response [CR] or Partial Response [PR] vs Not CR or PR) (Cohort I)Time frame: At 4 months
  3. Disease Control Rate (Cohort II)Time frame: At 12 months

Locations

141 sites in 3 countries. Site status is shown where the registry gives one.

  • Children's Hospital of Alabama

    Birmingham, Alabama

  • Phoenix Childrens Hospital

    Phoenix, Arizona

  • Banner University Medical Center - Tucson

    Tucson, Arizona

  • Arkansas Children's Hospital

    Little Rock, Arkansas

  • Kaiser Permanente-Anaheim

    Anaheim, California

  • Kaiser Permanente-Bellflower

    Bellflower, California

  • Kaiser Permanente Downey Medical Center

    Downey, California

  • Kaiser Permanente-Fontana

    Fontana, California

  • Loma Linda University Medical Center

    Loma Linda, California

  • Children's Hospital Los Angeles

    Los Angeles, California

  • Kaiser Permanente Los Angeles Medical Center

    Los Angeles, California

  • Valley Children's Hospital

    Madera, California

  • UCSF Benioff Children's Hospital Oakland

    Oakland, California

  • Children's Hospital of Orange County

    Orange, California

  • University of California Davis Comprehensive Cancer Center

    Sacramento, California

  • Kaiser Permanente-San Diego Zion

    San Diego, California

  • Rady Children's Hospital - San Diego

    San Diego, California

  • UCSF Medical Center-Mission Bay

    San Francisco, California

  • Children's Hospital Colorado

    Aurora, Colorado

  • Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center

    Denver, Colorado

  • Connecticut Children's Medical Center

    Hartford, Connecticut

  • Alfred I duPont Hospital for Children

    Wilmington, Delaware

  • Children's National Medical Center

    Washington D.C., District of Columbia

  • University of Florida Health Science Center - Gainesville

    Gainesville, Florida

  • Nemours Children's Clinic-Jacksonville

    Jacksonville, Florida

  • University of Miami Miller School of Medicine-Sylvester Cancer Center

    Miami, Florida

  • Nicklaus Children's Hospital

    Miami, Florida

  • AdventHealth Orlando

    Orlando, Florida

  • Nemours Children's Hospital

    Orlando, Florida

  • Johns Hopkins All Children's Hospital

    St. Petersburg, Florida

  • Saint Joseph's Hospital/Children's Hospital-Tampa

    Tampa, Florida

  • Saint Mary's Hospital

    West Palm Beach, Florida

  • Children's Healthcare of Atlanta - Egleston

    Atlanta, Georgia

  • Kapiolani Medical Center for Women and Children

    Honolulu, Hawaii

  • Saint Luke's Cancer Institute - Boise

    Boise, Idaho

  • Centralia Oncology Clinic

    Centralia, Illinois

  • Lurie Children's Hospital-Chicago

    Chicago, Illinois

  • University of Illinois

    Chicago, Illinois

  • University of Chicago Comprehensive Cancer Center

    Chicago, Illinois

  • Carle at The Riverfront

    Danville, Illinois

Showing 40 of 141 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.